Dr Reddy's launches skincare products in India
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories has launched the skincare products, Strea C10 (pure topical vitamin C 10%) and Strea A15 (pure topical retinol 0.15%), in India. The products, which are licensed from Italy's Vermont Italia, use microsphere technology and are available in vegicap soft-gel capsule form. The products are used to treat wrinkles, age spots, melasma, hyperpigmentation, photo-ageing and post-procedure inflammation, and can also be used alongside sun screens.
You may also be interested in...
Sun’s Ilumya To Claw Into Japanese Psoriasis Market
Tildrakizumab debuts in Japan, marking a key milestone for Sun Pharma, though heavyweight competitors including same class rival Skyrizi are already available on the market there.
'Covidization' Of Resources Brings Huge Disruption For TB Patients, Researchers
Redirection of healthcare resources to tackle COVID-19 is posing huge challenges for TB care and researchers in the area. Companies like J&J have stepped in to support, among other aspects, innovative community-based solutions to ensure continuity of care for drug resistant-TB patients amid the pandemic.
Ex-Cipla Executive To Helm JB Chemicals
The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.
Need a specific report? 1000+ reports available Buy Reports